Dr Pierre-Jean Lamy is an oncogeneticist specialist in biomarkers of solid tumors. He graduated from the Rockefeller Medical and Pharmaceutical University in Lyon, France in 1992, before joining the Montpellier Cancer Institute in 1997. He was the Head of the Department of Biology in which he developed a molecular laboratory dedicated to the detection of DNA alterations in solid tumors. Research on cancer biomarkers has been the main focus of his work for more than 20 years. Dr Lamy has also held the coordination of the Montpellier Cancer Institute Biobank. He led many translational research projects on prognosis and predictive biomarkers. His research aims to improve personalized medicine, focusing on molecular-targeted agents and related biomarkers. Dr Lamy has authored more than 100 publications, book chapters and was invited in numerous international scientific meetings. Dr Lamy is currently the medical director of IMAGENOME, "Institut d'Analyse Génomique", which is part of INOVIE, the 1st private clinical laboratory group in France.